3 European Projects Found
Searched on 125080 European Projects
FINISHED
Mutanome Engineered RNA Immuno-Therapy (MERIT)
Start date: Jun 1, 2013, End date: Nov 30, 2017,
...inical-grade RNA to produce a) a warehouse of therapeutic vaccines targeting shared antigens and b) custom therapeutic vaccines targeting patient-specific mutations. Upon success, partner BioNTech will move the therapeutics to advanced clinical trials and commercial applications for the benefit of triple negative breast cancer patients and other solid tumours.
Read Project
5
Partners Participants
FINISHED
Initial Training Network for Neurogical disorders orchestrated by cytoKines (NEUROKINE)
Start date: Jan 1, 2013, End date: May 31, 2017,
Neuroinflammatory disease, in particular multiple sclerosis affects more than 700.000 people within Europe alone. European countries are at the forefront of neuroimmunological research and students in medicine and biology are greatly attracted by the field. Neuroimmunology research further impacts our understanding of the ethiopathology of other CNS-disorders including Alzheimer’s Dementia and Mor ...
Read Project
13
Partners Participants
FINISHED
Glioma Actively Personalized Vaccine Consortium (GAPVAC)
Start date: Nov 1, 2012, End date: Jan 31, 2017,
"Glioblastoma (GBM) is a rare (2-3 incidences in 100,000) and fatal disease. Each year, approximately 13,000 new cases of GBM are diagnosed in Europe. The 5-year survival rate of this highly aggressive tumor entity under conventional therapy is less than 6%. Currently available therapeutic options neglect the individuality of each patients’ disease and only temporarily influence tumor progression ...
Read Project
